Compound Detail
CHEMBL5562344
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5562344 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | NWARZTAQZRDFKR-PGRDOPGGSA-N |
2
Targets
2
Activities
2
Assay Types
14
PK Parameters
17
Publications
0
Known Names
Molecular Properties
402.5
MW (Da)
3.63
ALogP
6
HBA
2
HBD
77.4
PSA (Ų)
0.63
QED
0
Ro5 Violations
10
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 1 meas. best 6.72
IC50 1 meas. best 6.77
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| 3',5'-cyclic-AMP phosphodiesterase 4D CHEMBL288 | IC50 | 6.77 | 6.77 | 170.0 | 1 |
| Unchecked CHEMBL612545 | EC50 | 6.72 | 6.72 | 190.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 429.84 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 436.77 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 373.7 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 381.15 | ng.hr.mL-1 | Rattus norvegicus |
| CL | 193.17 | mL.min-1.kg-1 | Rattus norvegicus |
| Cmax | 1.347 | ug.mL-1 | Rattus norvegicus |
| Cmax | 0.7183 | ug.mL-1 | Rattus norvegicus |
| F | 43.47 | % | Rattus norvegicus |
| MRT | 0.19 | hr | Rattus norvegicus |
| MRT | 0.49 | hr | Rattus norvegicus |
| T1/2 | 0.18 | hr | Rattus norvegicus |
| T1/2 | 0.34 | hr | Rattus norvegicus |
| Tmax | 0.08 | hr | Rattus norvegicus |
| Tmax | 0.25 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| 3',5'-cyclic-AMP phosphodiesterase 4D | IC50 | = | 170.0 | nM | 6.77 | Inhibition of human PDE4D catalytic domain (T86 to S413 residues) expressed in E... | 38489246 |
| Unchecked | EC50 | = | 190.0 | nM | 6.72 | Inhibition of LPS-induced TNF-alpha production in human PBMC cells pretreated fo... | 38489246 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 38489246 | 10.1021/acs.jmedchem.3c02424 | ADMET | 19 |
| 38489246 | 10.1021/acs.jmedchem.3c02424 | Unchecked | 12 |
| 38489246 | 10.1021/acs.jmedchem.3c02424 | Mus musculus | 8 |
| 38489246 | 10.1021/acs.jmedchem.3c02424 | 3',5'-cyclic-AMP phosphodiesterase 4D | 3 |
| 38489246 | 10.1021/acs.jmedchem.3c02424 | Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 1 |
| 38489246 | 10.1021/acs.jmedchem.3c02424 | cGMP-dependent 3',5'-cyclic phosphodiesterase | 1 |
| 38489246 | 10.1021/acs.jmedchem.3c02424 | cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A | 1 |
| 38489246 | 10.1021/acs.jmedchem.3c02424 | cGMP-specific 3',5'-cyclic phosphodiesterase | 1 |
| 38489246 | 10.1021/acs.jmedchem.3c02424 | Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' | 1 |
| 38489246 | 10.1021/acs.jmedchem.3c02424 | High affinity 3',5'-cyclic-AMP phosphodiesterase 7A | 1 |
| 38489246 | 10.1021/acs.jmedchem.3c02424 | High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A | 1 |
| 38489246 | 10.1021/acs.jmedchem.3c02424 | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | 1 |
| 38489246 | 10.1021/acs.jmedchem.3c02424 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 1 |
| 38489246 | 10.1021/acs.jmedchem.3c02424 | Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A | 1 |
| 38489246 | 10.1021/acs.jmedchem.3c02424 | 3',5'-cyclic-AMP phosphodiesterase 4A | 1 |
| 38489246 | 10.1021/acs.jmedchem.3c02424 | 3',5'-cyclic-AMP phosphodiesterase 4B | 1 |
| 38489246 | 10.1021/acs.jmedchem.3c02424 | No relevant target | 1 |
Data from ChEMBL 36 via Core Engine